Wildtype is the first cultivated seafood company in the world to get full regulatory authorization to sell its product, and in addition to making its cultivated lox available directly to consumers, the company introduced cultivated salmon skincare using the same cells.
In 2018, Wildtype took a sample of cells from one Pacific salmon to create real salmon—not plant-based, farm-raised, or wild-caught—grown in clean tanks without antibiotics or exposure to mercury or parasites. TIME named the ready-to-eat Wildtype lox one of the Best Inventions of 2025. Now, the company is introducing its first skincare products with Marine Cellular Complex to share the benefits of real salmon PDRN, plus peptides, high-density exosomes, antioxidants and growth factors for a firmer, replenished look as a result of softened fine lines and a calm, hydrated, radiant complexion.
Cultivated Salmon Skincare
Wildtype Created a First-of-Its-Kind Marine Complex for Skin
Trend Themes
-
Cell-cultivated Beauty — Lab-grown animal cells are expanding cosmetic ingredient sourcing with traceable, contaminant-controlled bioactives that can differentiate premium skincare without relying on wild extraction.
-
Marine Biotech Actives — Salmon-derived PDRN, exosomes, peptides and growth factors signal a new class of marine-inspired formulations positioned around regeneration, hydration and visible skin repair.
-
Cross-category Cellular Agriculture — Food-tech platforms are moving into personal care as the same cultivated biomass creates high-value applications beyond edible products and improves commercial scalability.
Industry Implications
-
Skincare — Clinical-grade bioactive complexes from cultivated sources offer brands a pathway to high-performance anti-aging products with stronger sustainability and purity narratives.
-
Cellular Agriculture — The use of seafood cells in both lox and topical formulations broadens revenue potential for cultivated protein companies through premium non-food ingredient markets.
-
Biotechnology — Advanced cell culture, exosome production and growth-factor stabilization are becoming commercial tools for translating regenerative science into consumer-facing products.